Endocrine Abstracts

Background: Secondary hyperparathyroidism (HPT) is a common complication seen in 12-54% of end stage renal disease patients (ESRD), owing to the calcium and phosphorus perturbations in these patients1. Successful kidney transplantation (KT) is expected to correct these abnormalities, however, it is not uncommon for hyperparathyroidism to persists post-transplantation 2,4,5,22. Persistent hyperparathyroidism is associated with significant mortality and mor...